The volume of sequence information from the human genome project demands the development of a tool to rapidly scan DNA for mutations. Such a technology would also be valuable in cancer research as a tool to detect early mutation events. Today, single nucleotide polymorphisms (SNPs), are routinely detected using methods that rely largely on the separation of DNA fragments by gel electrophoresis or HPLC, neither of which are readily suited to high throughput analysis. This review discusses how Biacore’s SPR technology may come to fill this role
Single nucleotide polymorphisms (SNPs) are the most common form of human genetic variation, with mil...
In the present review we describe a new methodology employing surface plasmon resonance (SPR) and bi...
that examines the genetic basis for individual variations in response to therapeutics. Pharmacogenet...
Single nucleotide polymorphism (SNP) detection technologies are used to scan for new polymorphisms a...
Detection of single nucleotide polymorphisms (SNPs) is a crucial challenge in the development of a n...
sent an emerging technology for genotyping. We devel-oped methods for detection of single-nucleotide...
Studies on genetic variation can reveal effects on traits and disease, both in humans and in model o...
Digital single-nucleotide polymorphism (SNP) analysis is developed to amplify a single tem-plate fro...
The objective of this program is to develop innovative mass spectrometry technology to achieve fast ...
Cancer is a genetic disease induced by mutations in DNA, in particular point mutations in important ...
Globally more than 100 million SNPs in populations. These variations approximately 4–5 million SNPs ...
The objective of this program is to develop innovative mass spectrometry technology to achieve fast ...
BACKGROUND: Single nucleotide polymorphisms (SNP) have proven to be powerful genetic markers for gen...
A current trend in biological science is the increased use of computational tools for both the produ...
Single Nucleotide Polymorphism (SNP) discovery and screening are important for disease discovery and...
Single nucleotide polymorphisms (SNPs) are the most common form of human genetic variation, with mil...
In the present review we describe a new methodology employing surface plasmon resonance (SPR) and bi...
that examines the genetic basis for individual variations in response to therapeutics. Pharmacogenet...
Single nucleotide polymorphism (SNP) detection technologies are used to scan for new polymorphisms a...
Detection of single nucleotide polymorphisms (SNPs) is a crucial challenge in the development of a n...
sent an emerging technology for genotyping. We devel-oped methods for detection of single-nucleotide...
Studies on genetic variation can reveal effects on traits and disease, both in humans and in model o...
Digital single-nucleotide polymorphism (SNP) analysis is developed to amplify a single tem-plate fro...
The objective of this program is to develop innovative mass spectrometry technology to achieve fast ...
Cancer is a genetic disease induced by mutations in DNA, in particular point mutations in important ...
Globally more than 100 million SNPs in populations. These variations approximately 4–5 million SNPs ...
The objective of this program is to develop innovative mass spectrometry technology to achieve fast ...
BACKGROUND: Single nucleotide polymorphisms (SNP) have proven to be powerful genetic markers for gen...
A current trend in biological science is the increased use of computational tools for both the produ...
Single Nucleotide Polymorphism (SNP) discovery and screening are important for disease discovery and...
Single nucleotide polymorphisms (SNPs) are the most common form of human genetic variation, with mil...
In the present review we describe a new methodology employing surface plasmon resonance (SPR) and bi...
that examines the genetic basis for individual variations in response to therapeutics. Pharmacogenet...